Literature DB >> 34309227

Impact of vision disorders and vision impairment on motor vehicle crash risk and on-road driving performance: A systematic review.

Joanne M Wood1, Alex A Black1, Kaeleen Dingle2, Cameron Rutter3, Marilyn DiStefano4, Sjaan Koppel5, Judith L Charlton5, Sharon A Bentley1.   

Abstract

Vision is important for safe driving, but there is limited understanding regarding the impact of vision disorders on driving ability and safety. This systematic review evaluated and summarized evidence on the impact of vision disorders and impairment on motor vehicle crash (MVC) risk and on-road driving performance across seven databases, was prospectively registered with PROSPERO (CRD42020180135), and study quality rated using a standard tool. Forty-eight studies met the inclusion criteria for MVC risk (N = 36), on-road performance (N = 9), and both MVC risk and on-road performance (N = 3). Of these studies, less than half were rated as 'good' quality. Due to the small number of studies and often conflicting findings, it was not possible to draw firm conclusions for most vision disorders. However, evidence from several 'good' and 'fair' quality studies suggested increased MVC risk with binocular visual field impairment. There was mixed evidence regarding the impact of cataract, glaucoma, age-related macular degeneration and homonymous field loss on MVC risk and no evidence of increased MVC risk with mild VA impairment. This review highlights the need for well-designed future studies to further explore the impact of vision disorders and impairment on driving outcomes to inform evidence-based policy and fitness to drive guidelines.
© 2021 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  driving ability; driving safety; motor vehicle crash risk; on-road driving performance; vision disorders; visual impairment

Mesh:

Year:  2021        PMID: 34309227     DOI: 10.1111/aos.14908

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  1 in total

1.  Driving and exceptional cases: Supporting relicensing evaluation in patients whose visual fields fail to meet standards.

Authors:  Robert A Harper; Jeremy A Parkes; Christine M Dickinson
Journal:  Ophthalmic Physiol Opt       Date:  2022-06-10       Impact factor: 3.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.